Toxoplasmosis in Cats: Vertical Transmission and Public Health Implications

Introduction

Toxoplasmosis is a globally distributed parasitic zoonosis caused by the obligate intracellular apicomplexan protozoan Toxoplasma gondii. Felids, particularly domestic cats (Felis catus), serve as the definitive hosts in which the sexual phase of the parasite life cycle occurs, leading to the shedding of environmentally resistant oocysts [1, 2]. The potential for vertical (transplacental) transmission in both feline and human hosts represents a critical component of the parasite's epidemiology and clinical impact. Understanding the mechanisms of vertical transmission, diagnostic strategies, and public health risks is essential for veterinary practitioners, diagnosticians, and public health professionals. This review synthesizes recent advances in the biology, epidemiology, diagnosis, and management of feline toxoplasmosis, with particular emphasis on vertical transmission and its implications for cat toxoplasmosis baby risk.

Etiology and Life Cycle

Toxoplasma gondii exists in three principal infectious stages: tachyzoites (rapidly dividing invasive form), bradyzoites (slowly dividing, encysted form within tissue cysts), and sporozoites (within sporulated oocysts) [2]. The sexual cycle is restricted to the feline intestinal epithelium, where gametogony and fertilization produce unsporulated oocysts that are shed in feces [1, 3]. A single-cell atlas of T. gondii sexual development in the feline intestinal tract revealed the transcriptional landscape of male and female gamete formation, as well as stages of zygote and oocyst wall formation [1]. The transition from asexual to sexual development involves pre-sexual stages characterized by distinctive cell division patterns, including endodyogeny and endopolygeny [2]. MicroRNA expression dynamics within the feline small intestine during infection are associated with regulation of host immune responses and parasite differentiation [3].

Following ingestion of tissue cysts (bradyzoites) from intermediate hosts or sporulated oocysts from the environment, the parasite excysts in the gastrointestinal tract and transforms into tachyzoites that disseminate hematogenously [4]. In cats, the prepatent period (time from infection to oocyst shedding) ranges from 3 to 10 days after ingestion of tissue cysts, and 18 days or longer after ingestion of oocysts [2]. Shedding typically lasts 1 to 3 weeks, during which millions of oocysts may be released into the environment [1]. The microneme protein MIC17A has been identified as a promising marker for both entero-epithelial and chronic stages of feline toxoplasmosis, offering potential for stage-specific diagnostics [5].

Epidemiology

Seroprevalence of T. gondii in domestic cats varies widely by geographic region, management practices, and lifestyle factors. A study in Hong Kong reported seroprevalence rates of 8.6% in privately-owned cats and 22.1% in community cats, with significant associations with age and outdoor access [6]. In Jordan, first seroprevalence data in cats showed an overall rate of 34.8% with risk factors including age, free-roaming behavior, and consumption of raw meat [7]. A study in Brazil found high seroprevalence in dogs from the Pantanal region [8], and similar patterns have been observed in other domestic animals used as sentinels for environmental contamination [9, 10, 11, 12, 32].

Oocyst shedding is intermittent and often missed by single fecal examinations. Molecular detection of T. gondii DNA in fecal samples from stray cats in Bangkok revealed a prevalence of 5.2% by PCR, highlighting the potential for environmental contamination in urban settings [13]. Environmental degradation and social marginalization are associated with higher T. gondii exposure in human populations, reflecting the role of cat fecal contamination in soil and water sources [14]. Veterinary medicine professionals and students, due to occupational exposure, show elevated seroprevalence compared to the general population [15].

Vertical Transmission in Cats

Vertical transmission of T. gondii in cats occurs primarily through transplacental passage of tachyzoites during acute maternal infection. While less frequently documented than in sheep or humans, experimental studies have demonstrated that queens infected during early to mid-gestation can transmit infection to fetuses, resulting in abortion, stillbirth, or neonatal toxoplasmosis [16]. Examination of reproductive tissues from cats enrolled in a municipal neutering program detected T. gondii DNA in ovarian and uterine tissues, confirming that the parasite can localize to reproductive organs in naturally infected animals [16]. Comparable findings in other species, including aborted equine fetuses and caprine fetuses, support the biological plausibility of vertical transmission in felids [17, 18]. In humans, seropositivity and risk factors for abortion or stillbirth have been linked to T. gondii infection [19]. The term cat toxoplasmosis baby colloquially refers to the risk of congenital toxoplasmosis in human infants following maternal primary infection acquired from feline sources, a topic of substantial public health concern [29, 20].

Clinical Signs in Cats

The majority of T. gondii infections in cats are subclinical. Clinical disease is most commonly observed in immunocompromised animals (e.g., feline immunodeficiency virus or feline leukemia virus co-infection, or those receiving immunosuppressive therapy) and in very young kittens [33]. Ocular toxoplasmosis manifests as uveitis, chorioretinitis, and retinal detachment; these presentations are analogous to ocular toxoplasmosis in humans [30]. Neurological signs include seizures, ataxia, circling, and behavioral changes [21, 34]. Systemic disease may present with pyrexia, lethargy, anorexia, dyspnea, and icterus due to hepatic involvement. A case series of cats with pyogranulomatous lymphadenitis identified T. gondii as one of the etiologic agents, indicating that lymph node enlargement can be a feature of feline toxoplasmosis [33]. Parasite-induced behavioral changes in intermediate hosts have been described, though direct evidence in cats is limited [34]. The feline AB blood group phenotype does not influence susceptibility to infection [35].

Pathology

Necropsy findings in cats with disseminated toxoplasmosis include multifocal necrosis and inflammation in the liver, lungs, brain, and heart. Histopathologic examination reveals tachyzoites and tissue cysts (bradyzoites) within cells, often associated with a mixed inflammatory infiltrate containing macrophages, neutrophils, and lymphocytes [33]. In the central nervous system, cerebral toxoplasmosis presents as necrotizing encephalitis, and in immunocompromised hosts (including transplant recipients in comparative contexts), the condition can be life-threatening [21]. Myocardial necrosis and myositis are also observed. Tachyzoites can be identified in cytologic preparations from effusions, bronchoalveolar lavage, or cerebrospinal fluid, though sensitivity is low.

Diagnostics

Accurate diagnosis of feline toxoplasmosis requires a combination of serologic, molecular, and histopathologic techniques, as clinical signs are nonspecific.

Serologic Assays

Measurement of anti-T. gondii IgG and IgM antibodies by enzyme-linked immunosorbent assay (ELISA) is the most common screening method [22, 23]. A double-antigen sandwich colloidal gold immunochromatographic strip (ICS) has been developed for rapid detection of antibodies across multiple host species, including cats, and shows high sensitivity and specificity in field validation studies [22]. Similarly, a SAG1-based colloidal gold ICS for swine has potential cross-species application [23]. These point-of-care tests enable rapid serosurveillance without specialized laboratory equipment.

Molecular Detection

Polymerase chain reaction (PCR) targeting the B1 gene or 529-bp repetitive element is widely used for detection of T. gondii DNA in tissues, blood, and feces [13, 24, 16]. An antisense PCR assay developed specifically for domestic cats improves sensitivity by amplifying the complementary strand of the target sequence, reducing false negatives due to mismatches in primer binding [24]. Molecular detection in reproductive tissues has confirmed the presence of the parasite in the feline reproductive tract [16], and similar approaches have been applied to fetal tissues in other species [17, 18].

Histopathology and Immunohistochemistry

Histopathologic identification of tachyzoites and tissue cysts in biopsy or necropsy specimens, combined with immunohistochemical staining using anti-T. gondii antibodies, provides definitive diagnosis [18, 33]. Pyogranulomatous inflammation with intralesional organisms is pathognomonic. The MIC17A antigen can be targeted for immunohistochemical detection of both entero-epithelial and chronic stages [5].

Diagnostic Decision Tree

flowchart TD
    A[Feline patient with suspected toxoplasmosis], > B{Clinical signs consistent?}
    B, >|Yes| C[Collect serum and fecal sample]
    B, >|No| D[No further action]
    C, > E[Perform serology: ELISA or ICS]
    E, > F{Seropositive?}
    F, >|IgM positive or rising IgG| G[High probability of active infection]
    F, >|IgG positive, IgM negative| H[Past exposure]
    G, > I[Confirm with PCR on blood/feces or tissue biopsy]
    I, > J{PCR positive?}
    J, >|Yes| K[Confirmed active toxoplasmosis]
    J, >|No| L[Consider other causes; false negative possible]
    H, > M[No further diagnostics if asymptomatic]
    K, > N[Initiate antiprotozoal therapy]
    N, > O[Monitor clinical response and repeat serology]

Treatment

The primary treatment for clinical toxoplasmosis in cats is clindamycin (10 to 12 mg/kg orally every 12 hours for 2 to 4 weeks) [33]. Alternative options include trimethoprim-sulfonamide combinations, azithromycin, and atovaquone, though controlled feline trials are limited. Treatment is recommended only for cats with clinical disease; asymptomatic seropositive cats do not require therapy. In cases of ocular toxoplasmosis, topical corticosteroids may be used in conjunction with systemic antiprotozoal agents to control inflammation [30].

Control and Prevention

Preventing T. gondii infection in cats reduces the risk of oocyst shedding and environmental contamination. Key measures include feeding only cooked or commercially processed food, restricting outdoor access to prevent hunting of intermediate hosts, and maintaining a clean litter box with daily removal of feces (oocysts require 1 to 5 days to sporulate and become infectious) [29, 20].

Vaccine development is an active area of research. Gene-edited live-attenuated vaccines have shown promise in reducing oocyst shedding and preventing tissue cyst formation in animal models [4]. The transition to mRNA-based platforms and One Health approaches represents a translational frontier [25]. However, no licensed commercial vaccine is currently available worldwide.

Pregnant women seronegative for toxoplasmosis should avoid cleaning litter boxes or wear disposable gloves and wash hands thoroughly after handling potentially contaminated materials [29]. Educational interventions in primary care settings have improved knowledge of toxoplasmosis prevention among pregnant women [20], though knowledge gaps persist in some populations [26]. Community-level risk factors, including environmental degradation, are associated with higher exposure rates [14, 31].

Public Health Implications

The zoonotic risk posed by T. gondii oocysts shed by cats has profound implications for public health. Primary infection in immunocompetent humans is often asymptomatic, but can cause severe disease in immunocompromised individuals and in fetuses when maternal infection occurs during pregnancy [27, 21]. Congenital toxoplasmosis results from transplacental transmission of tachyzoites and can lead to abortion, stillbirth, chorioretinitis, intracranial calcifications, hydrocephalus, and neurodevelopmental deficits [19, 29]. The term cat toxoplasmosis baby encapsulates the public perception of this risk, which, while real, requires contextualization: indoor cats fed commercial diets pose minimal risk, whereas free-roaming cats with outdoor access are more likely to be infected and shed oocysts [6, 7].

Seroprevalence studies in women with adverse pregnancy outcomes continue to report associations with T. gondii [19], and risk factors including soil contact, consumption of raw meat, and cat ownership are consistently identified [31]. Knowledge surveys among university students reveal that awareness of toxoplasmosis and preventive measures is not uniformly high, emphasizing the need for ongoing education [26]. The association between T. gondii seropositivity and psychiatric disorders such as schizophrenia has been explored in population-based cohorts, with evidence linking infection to differences in grey matter volume [28].

From a One Health perspective, interspecies transmission dynamics involve cats, intermediate hosts (livestock and wildlife), and humans [25, 10]. Surveillance in animal populations, such as goats in quarantine facilities [10], dairy cattle [11], and wildlife [9, 8], helps map geographic risk. Ocular health outcomes in community-based studies underscore the chronic consequences of infection acquired early in life [30, 31].

Conclusion

Vertical transmission of Toxoplasma gondii in cats, though less frequent than in other hosts, is a biologically plausible and documented route that can lead to fetal loss and neonatal disease. The feline role as the definitive host places cats at the center of environmental contamination with oocysts, which in turn drives human exposure and the risk of congenital toxoplasmosis. Advances in molecular diagnostics, including antisense PCR and multiplex serologic assays, now allow sensitive detection of infection [22, 23, 24]. Ongoing vaccine development using gene-edited live-attenuated strains holds promise for reducing oocyst shedding [4, 25]. Effective public health intervention requires integration of veterinary diagnostics, husbandry practices, and community education to mitigate the risk of cat toxoplasmosis baby and protect vulnerable populations.

References

[1] Alrubaye HS, Reilly SM, da Silva R et al. A single-cell atlas of Toxoplasma sexual development in the feline intestinal tract. Nat Microbiol. 2026. https://pubmed.ncbi.nlm.nih.gov/42020723/

[2] Sena F, Hakimi M-A, Francia ME. Proliferating toward sex: characterization of cell division of Toxoplasma gondii's pre-sexual stages. mBio. 2026. https://pubmed.ncbi.nlm.nih.gov/42153709/

[3] Zhai B, Bao B, Xie SC et al. Dynamic landscape of microRNA expression in the feline small intestine during Toxoplasma gondii infection. Parasit Vectors. 2026. https://pubmed.ncbi.nlm.nih.gov/41965856/

[4] Sang X, Zhang H, Zhang Y et al. Gene-edited live-attenuated vaccines against Toxoplasma gondii: recent advances and future frontiers. Parasit Vectors. 2026. https://pubmed.ncbi.nlm.nih.gov/42252477/

[5] Günay-Esiyok Ö, Koçkaya ES, Yılmaz R et al. The Potential of MIC17A both as an Entero-epithelial and Chronic Stage Marker for Detection of Feline Toxoplasmosis. Curr Microbiol. 2026. https://pubmed.ncbi.nlm.nih.gov/41874672/

[6] Elsohaby I, Zubair M, Baqar Z et al. Seroprevalence of Toxoplasma gondii and associated demographic factors in privately-owned dogs, cats, and community cats in Hong Kong. BMC Vet Res. 2026. https://pubmed.ncbi.nlm.nih.gov/42135800/

[7] Alkhatatbeh SK, Lafi SQ, Hammad HB et al. The first seroprevalence and molecular detection of toxoplasmosis infecting cats in Jordan with associated risk factors. Vet Parasitol Reg Stud Reports. 2026. https://pubmed.ncbi.nlm.nih.gov/41741047/

[8] Artiaga-Silva GL, de Lima Ruy Dias ÁF, Carvalho MR et al. High Seroprevalence Rates of Toxoplasma gondii and Neospora caninum in Dogs in the Pantanal Region of Mato Grosso, Brazil. Acta Parasitol. 2026. https://pubmed.ncbi.nlm.nih.gov/41843222/

[9] Aziz KJ, Mikaeelb FB, Nasrullah OJ et al. Seroepidemiological investigation of Toxoplasma gondii and Neospora caninum in local Deers in Erbil, Iraq. Vet Parasitol Reg Stud Reports. 2026. https://pubmed.ncbi.nlm.nih.gov/42034957/

[10] Muhammad AS, Kudi AC, Mohammed A et al. Public health significance of prevalence and risk factors associated with Toxoplasma gondii infection in goats sampled from two quarantine facilities and an institutional farm in Maiduguri metropolis, Borno state, Nigeria. Sci Rep. 2026. https://pubmed.ncbi.nlm.nih.gov/42020619/

[11] Hanedan B, Taş BZ, Yıldırım E et al. Investigation of Toxoplasma gondii seroprevalence and associated risk factors in dairy cattle in the Eastern Anatolia region of Türkiye. Vet Parasitol Reg Stud Reports. 2026. https://pubmed.ncbi.nlm.nih.gov/41819961/

[12] Marín-García PJ, Ballesteros-García O, Martínez-Sáez L et al. Low seroprevalence of Toxoplasma gondii in pig farms (Sus scrofa domesticus) of eastern Spain in intensive farms with control of animal entry. Vet Parasitol Reg Stud Reports. 2026. https://pubmed.ncbi.nlm.nih.gov/41741032/

[13] Kengradomkij C, Chimnoi W, Kamyingkird K et al. PCR detection of Toxoplasma gondii DNA in fecal samples from stray cats in Bangkok Metropolitan, Thailand. Food Waterborne Parasitol. 2026. https://pubmed.ncbi.nlm.nih.gov/42094705/

[14] Eyre MT, Wang JY, Carneiro IO et al. Social marginalisation, environmental degradation and Toxoplasma gondii exposure in urban informal settlements in Brazil. PLoS Negl Trop Dis. 2026. https://pubmed.ncbi.nlm.nih.gov/42330015/

[15] de Velasco-Reyes I, Torres-García SE, Hernández-Rangel JJ et al. Seroprevalence of Toxoplasma gondii Infection in Veterinary Medicine Professionals and Students in Aguascalientes, Mexico. Epidemiologia (Basel). 2026. https://pubmed.ncbi.nlm.nih.gov/42201205/

[16] Murata FHA, Barboza JP, de Souza CAG et

[17] Pinto GOA, Silva RAD, Oliveira PRF et al. Molecular detection of Toxoplasma gondii in an aborted equine fetus and serological evidence of infection in mares enrolled in embryo transfer programs in Brazil. J Equine Vet Sci. 2026. https://pubmed.ncbi.nlm.nih.gov/42252005/

[18] Ait Issad N, Mohamed Cherif A, Mebkhout F et al. First report of molecular and histopathological detection of Toxoplasma gondii in aborted fetal goat myocardium in Algeria with associated risk factors. Parasitol Int. 2026. https://pubmed.ncbi.nlm.nih.gov/41864556/

[19] Karacali B, Mor N. Investigation of anti-Toxoplasma gondii antibody seropositivity and possible risk factors in women with abortion or stillbirth history in Kars, Turkey. Afr J Reprod Health. 2026. https://pubmed.ncbi.nlm.nih.gov/42202767/

[20] Henriette BA, Jémima EK, Jean-Sébastien MA et al. First report of knowledge and practices towards toxoplasmosis among pregnant women in primary care in Abidjan, Côte d'Ivoire. Trop Parasitol. 2026. https://pubmed.ncbi.nlm.nih.gov/42199683/

[21] Mihaljević D, Sitaš Z, Hanulak J et al. Cerebral Toxoplasmosis in a Renal Transplant Recipient-A Rare Complication. Life (Basel). 2026. https://pubmed.ncbi.nlm.nih.gov/41900989/

[22] Mu X, Chen C, Pu X et al. Development and Field Validation of a Double-Antigen Sandwich Colloidal Gold Immunochromatographic Strip for Detection of Toxoplasma gondii Antibodies in Multiple Host Species. Transbound Emerg Dis. 2026. https://pubmed.ncbi.nlm.nih.gov/42253330/

[23] Chen XX, Sun H, Liang Y et al. Development of a SAG1-based colloidal gold immunochromatographic strip for rapid serological detection of swine Toxoplasma gondii. Parasit Vectors. 2026. https://pubmed.ncbi.nlm.nih.gov/42169035/

[24] Li YY, Bai SY, Yu HQ et al. Development and evaluation of an antisense PCR assay for Toxoplasma gondii detection in domestic cats. Vet Parasitol. 2026. https://pubmed.ncbi.nlm.nih.gov/41724116/

[25] Qadeer A, Tharwat M, Khan MZ et al. Advances and Translational Challenges in Toxoplasma gondii Vaccine Development: From Antigen Discovery to mRNA and One Health Strategies. Vet Sci. 2026. https://pubmed.ncbi.nlm.nih.gov/42188907/

[26] Chalabi KN, Jabar Bakr E. Toxoplasmosis - knowledge among university students in Erbil, Iraq: a cross-sectional study. Int J Environ Health Res. 2026. https://pubmed.ncbi.nlm.nih.gov/41873025/

[27] Orish VN, Tetteh RE, Adzah D et al. Toxoplasma gondii seropositivity among patients with sickle cell disease: Prevalence and association with blood transfusion history. PLoS One. 2026. https://pubmed.ncbi.nlm.nih.gov/41931585/